Transfusion Requirements in Cardiac Surgery III (TRICS III): Study Design of a Randomized Controlled Trial

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 32, Issue 1, 2018, Pages 121-129

  Shehata, Nadine ^a   Whitlock, Richard ^b   Fergusson, Dean A ^c   Thorpe, Kevin E ^d   MacAdams, Charlie ^e   Grocott, Hilary P ^f   Rubens, Fraser ^g   Fremes, Stephen ^h   Lellouche, Francois ⁱ   Bagshaw, Sean ^j   Royse, Alistair ^k   Rosseel, Peter M ^l   Hare, Greg ^d   Medicis, Etienne De ^m   Hudson, Christopher ^g   Belley Cote, Emilie ^b   Bainbridge, Daniel ⁿ   Kent, Blaine ^o   Shaw, Andrew ^p   Byrne, Kelly ^q   Syed, Summer ^b   Royse, Colin F ^e,k   McGuiness, Shay ^r   Hall, Judith ^d   Mazer, C David ^d   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f UNIVERSITY OF MANITOBA   (Canada)

^g UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^h SUNNYBROOK RESEARCH INSTITUTE   (Canada)

ⁱ UNIVERSITÉ LAVAL   (Canada)

^j UNIVERSITY OF ALBERTA   (Canada)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l AMPHIA HOSPITAL   (Netherlands)

^m CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

ⁿ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^o DALHOUSIE UNIVERSITY   (Canada)

^p VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^q WAIKATO HOSPITAL   (New Zealand)

^r AUCKLAND CITY HOSPITAL   (New Zealand)

more..

Author keywords

cardiac surgery; randomized controlled trial; transfusion

Indexed keywords

FIBRINOGEN; FIBRINOGEN CONCENTRATE; HEMOGLOBIN; PROTHROMBIN COMPLEX;

ADULT; ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; EUROSCORE; FIBRINOGEN BLOOD LEVEL; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MORBIDITY; MULTICENTER STUDY; OPEN STUDY; PATIENT SAFETY; PEROPERATIVE CARE; PILOT STUDY; PLATELET COUNT; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL MORTALITY; SURGICAL PATIENT; THROMBOCYTE TRANSFUSION; AGED; BLOOD TRANSFUSION; CLINICAL TRIAL; FEMALE; INTERNATIONAL COOPERATION; MALE; METABOLISM; MIDDLE AGED; PROCEDURES;

AGED; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBINS; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 85038640913     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2017.10.036     Document Type: Article

References (37)

1. STS Adult Cardiac Surgery Database. Available at: http://www.sts.org/sites/default/files/documents/2012-AC-4thHarvestExecutiveSummary.pdf. Accessed September 2017.
2. Hung, M., Ortmann, E., Besser, M., et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients. Heart 101 (2015), 107–112.
3. Karkouti, K., Wijeysundera, D.N., Beattie, W.S., Risk associated with preoperative anemia in cardiac surgery: A multicenter cohort study. Circulation 117 (2008), 478–484.
4. Miceli, A., Romeo, F., Glauber, M., et al. Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery. J Cardiothorac Surg, 9, 2014, 137.
5. Delaney, M., Wendel, S., Bercovitz, R.S., et al. Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion reactions: Prevention, diagnosis, and treatment. Lancet. 388 (2016), 2825–2836.
6. Shehata, N., Burns, L.A., Nathan, H., et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 52 (2012), 91–99.
7. Transfusion Requirements in Cardiac Surgery II. Available at: http://clinicaltrials.gov/ct2/show/NCT01484639?term=red+cell+transfusion+and+cardiac+surgery&rank=1.
8. Nashef, S.A., Roques, F., Hammill, B.G., et al. Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg 22 (2002), 101–105.
9. Geissler, H.J., Holzl, P., Marohl, S., et al. Risk stratification in heart surgery: Comparison of six score systems. Eur J Cardiothorac Surg 17 (2000), 400–406.
10. Surgenor, S.D., Kramer, R.S., Olmstead, E.M., et al., Northern New England Cardiovascular Disease Study Group. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 108 (2009), 1741–1746.
11. Covin, R., O'Brien, M., Grunwald, G., et al. Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery. Arch Pathol Lab Med 127 (2003), 415–423.
12. Shehata, N., Wilson, K., Mazer, C.D., et al. Factors affecting perioperative transfusion decisions in patients with coronary artery disease undergoing coronary artery bypass surgery. Anesthesiology 105 (2006), 19–27.
13. Arora, R.C., Legare, J.-F., Buth, K.J., et al. Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: Toward selective conservation strategies. Ann Thor Surg 78 (2004), 1547–1555.
14. Shehata, N., Naglie, G., Alghamdi, A.A., et al. Risk factors for red cell transfusion in adults undergoing coronary artery bypass surgery: A systematic review. Vox Sang 93 (2007), 1–11.
15. Deans, K.J., Minneci, P.C., Suffredini, A.F., et al. Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols. Crit Care Med 35 (2007), 1509–1516.
16. Schulz, K.F., Altman, D.G., Moher, D., et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 152 (2010), 726–732.
17. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris, V.A., Ferraris, S.P., et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83 (2007), S27–S86.
18. Weiskopf, R.B., Viele, M.K., Feiner, J., et al. Human cardiovascular and metabolic response to acute severe isovolemic anemia. JAMA 279 (1998), 217–221.
19. Hébert, P.C., Yetisir, E., Martin, C., et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med 29 (2001), 227–234.
20. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. Circulation 126 (2012), 2020–2035.
21. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2 (2012), 1–138.
22. Confusion Assessment Method for the ICU (CAM-ICU) Available at: http://www.icudelirium.org/docs/CAM_ICU_training.pdf. Accessed August 2017.
23. Intensive Care Delirium Screening Checklist (ICDSC). Available at: http://www.lhsc.on.ca/Health_Professionals/CCTC/elearning/bedside_sheets_CCTC_icdsc.pdf. Accessed August 2017.
24. Tuman, K.J., McCarthy, R.J., March, R.J., et al. Morbidity and duration of ICU stay after cardiac surgery. A model for preoperative risk assessment. Chest 102 (1992), 36–44.
25. Higgins, T.L., Estafanous, F.G., Loop, F.D., et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 267 (1992), 2344–2348.
26. Curley, G.F., Shehata, N., Mazer, C.D., et al. Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: A systematic review and meta-analysis. Crit Care Med 42 (2014), 2611–2624.
27. Whitlock, R.P., Whitlock, R.P., Devereaux, P.J., et al. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): A randomised, double-blind, placebo-controlled trial. Lancet 386 (2015), 1243–1253.
28. Scott, B.H., Seifert, F.C., Grimson, R., Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Annals Cardiac Anesth 11 (2008), 15–19.
29. Surgenor, S.D., Kramer, R.S., Olmstead, E.M., et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 108 (2009), 1741–1746.
30. Bracey, A.W., Radovancevic, R., Riggs, S.A., et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: Effect on patient outcome. Transfusion 39 (1999), 1070–1077.
31. Blumberg, N., Heal, J.M., Gettings, K.F., et al. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 50 (2010), 2738–2744.
32. Gøtzsche, P.C., Lessons from and cautions about noninferiority and equivalence randomized trials. JAMA 295 (2006), 1172–1174.
33. Hébert, P.C., Wells, G., Blajchman, M.A., et al. A multicenter, randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340 (1999), 409–417.
34. Carson, J.L., Terrin, M.L., Noveck, H., et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 365 (2011), 2453–2462.
35. Brunskill, S.J., Millette, S.L., Shokoohi, A., et al. Red blood cell transfusion for people undergoing hip fracture surgery. Cochrane Database of Systematic Reviews, 2015, 4 CD009699.
36. Murphy, G.J., Pike, K., Rogers, C.A., et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 372 (2015), 997–1008.
37. Loor, G., Li, L., Sabik, J.F. 3rd, et al. Nadir hematocrit during cardiopulmonary bypass: End-organ dysfunction and mortality. J Thorac Cardiovasc Surg 144 (2012), 654–662.